Abraxis BioScience, Inc. 4
4 · Abraxis BioScience, Inc. · Filed Oct 19, 2010
Insider Transaction Report
Form 4
Transactions
- Disposition to Issuer
Common Stock
2010-10-15−5,758,757→ 0 total
Footnotes (1)
- [F1]Disposed of pursuant to the Agreement and Plan of Merger, dated as of June 30, 2010, among Celgene Corporation ("Celgene"), Artistry Acquisition Corp. ("Merger Sub") and Abraxis BioScience, Inc. ("Abraxis"), whereby Merger Sub merged into Abraxis, with Abraxis continuing as the surviving company and a wholly owned subsidiary of Celgene (the "Merger"), in exchange for (i) an amount in cash equal to $58.00, (ii) 0.2617 of a share of Celgene common stock and (iii) a contingent value right issued by Celgene.